Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-masked, Placebo-controlled Study With Open-label Period to Evaluate the Efficacy and Safety of MEDI-551 in Adult Subjects With Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders.

NCT02200770 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT02200770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02200770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-masked, Placebo-controlled Study With Open-label Period to Evaluate the Efficacy and Safety of MEDI-551 in Adult Subjects With Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders.
Lead sponsor
MedImmune LLC
Phase
Phase 2/3
Overall status
Completed
Start date
April 1, 2015
Completion date
November 6, 2020
Enrollment
231 (actual)
Sites
98

Conditions

As the registry lists them; a condition with its own page is linked.

neuromyelitis optica and neuromyelitis optica spectrum disorders